Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹205 Cr₹84 Cr₹57 Cr₹24 Cr₹24 Cr

What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?

The latest Total Non-Current Liabilities ratio of MARKSANS PHARMA is ₹205 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹205 Cr
Mar2023₹84 Cr
Mar2022₹57 Cr
Mar2021₹24 Cr
Mar2020₹24 Cr

How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹205 Cr
143.34
Mar2023 ₹84 Cr
47.80
Mar2022 ₹57 Cr
140.72
Mar2021 ₹24 Cr
-1.88
Mar2020 ₹24 Cr -

Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹10,840.5 Cr 1.2% -16.2% 61.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,472.0 Cr 0.2% -5.8% 23.9% Stock Analytics
DIVIS LABORATORIES ₹156,342.0 Cr 4.8% 0% 53.8% Stock Analytics
CIPLA ₹114,754.0 Cr -0.2% -4.7% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,465.0 Cr 1.9% -10.9% 0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹96,875.2 Cr 3.2% 0.1% 28.1% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

1.2%

-16.2%

61.6%

SENSEX

1.7%

-2.6%

7.6%


You may also like the below Video Courses